ROTHBLATT MARTINE A
SEC CIK 1106578 · EDGAR
BoughtSold
Most active insiders at UTHR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROTHBLATT MARTINE A | COB, CEO, Dir | -$863.9K | $841.11M |
| 2 | BENKOWITZ MICHAEL | Pres AND COO | — | $226.97M |
| 3 | EDGEMOND JAMES | CFO AND Treas | — | $211.57M |
| 4 | MAHON PAUL A | EVP, GC | — | $114.08M |
| 5 | SULLIVAN LOUIS W | Dir | — | $3.05M |
| 6 | PATUSKY CHRISTOPHER | Dir | — | $2.73M |
| 7 | Thompson Tommy G | Dir | — | $2.51M |
| 8 | KURZWEIL RAY | Dir | — | $2.40M |
| 9 | CAUSEY CHRISTOPHER | Dir | — | $2.33M |
| 10 | Olian Judy D. | Dir | — | $417.0K |
Transactions 665
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-15 | 2022-12-13+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $277.38 | -16.0K | 197 | -99% | -$4.44M |
| DM | 2022-12-15 | 2022-12-13+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2022-12-13 | 2022-12-09+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $279.96 | -16.0K | 7,370 | -68% | -$4.48M |
| DM | 2022-12-13 | 2022-12-09+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2022-12-09 | 2022-12-07+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $277.21 | -16.0K | 3,460 | -82% | -$4.44M |
| DM | 2022-12-09 | 2022-12-07+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2022-12-07 | 2022-12-05+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $272.96 | -16.0K | 2,549 | -86% | -$4.37M |
| DM | 2022-12-07 | 2022-12-05+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2022-12-05 | 2022-12-01+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $278.18 | -16.0K | 3,683 | -81% | -$4.45M |
| DM | 2022-12-05 | 2022-12-01+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2022-12-01 | 2022-11-29+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $273.85 | -16.0K | 5,226 | -75% | -$4.38M |
| DM | 2022-12-01 | 2022-11-29+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2022-11-29 | 2022-11-25+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $268.67 | -16.0K | 130 | -99% | -$4.30M |
| DM | 2022-11-29 | 2022-11-25+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2022-11-25 | 2022-11-22+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $268.42 | -16.0K | 2,891 | -85% | -$4.29M |
| DM | 2022-11-25 | 2022-11-22+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2022-11-21 | 2022-11-18+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $265.45 | -16.0K | 5,298 | -75% | -$4.25M |
| DM | 2022-11-21 | 2022-11-18+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2022-11-18 | 2022-11-16+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $261.52 | -16.0K | 2,239 | -88% | -$4.18M |
| DM | 2022-11-18 | 2022-11-16+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | 0 | 8,130 | New | $0 |
| DM | 2022-11-16 | 2022-11-14+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $258.21 | -16.0K | 304 | -98% | -$4.13M |
| DM | 2022-11-16 | 2022-11-14+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2022-11-14 | 2022-11-10+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2022-11-14 | 2022-11-10+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $258.55 | -16.0K | 685 | -96% | -$4.14M |
| DM | 2022-11-10 | 2022-11-09 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $264.45 | -8,000 | 6,218 | -56% | -$2.12M |
| D | 2022-11-10 | 2022-11-09 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +8,000 | 8,130 | +6,154% | +$904.6K |
| DM | 2022-11-09 | 2022-11-07+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2022-11-09 | 2022-11-07+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $265.18 | -16.0K | 6,365 | -72% | -$4.24M |
| DM | 2022-11-04 | 2022-11-03+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2022-11-04 | 2022-11-03+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $264.41 | -16.0K | 7,111 | -69% | -$4.23M |
| DM | 2022-11-03 | 2022-11-01+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $239.93 | -16.0K | 430 | -97% | -$3.84M |
| DM | 2022-11-03 | 2022-11-01+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2022-06-03 | 2022-06-01+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $229.85 | -3,579 | 130 | -96% | -$822.6K |
| DM | 2022-06-03 | 2022-06-01+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $54.17 | +3,579 | 709 | New | +$193.9K |
| DM | 2022-06-01 | 2022-05-27+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $231.06 | -6,000 | 2,199 | -73% | -$1.39M |
| DM | 2022-06-01 | 2022-05-27+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $53.42 | +6,000 | 3,130 | New | +$320.5K |
| DM | 2022-05-26 | 2022-05-25+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $223.93 | -6,000 | 2,961 | -67% | -$1.34M |
| DM | 2022-05-26 | 2022-05-25+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $53.42 | +6,000 | 3,130 | New | +$320.5K |
| DM | 2022-05-25 | 2022-05-23+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $213.07 | -6,000 | 2,065 | -74% | -$1.28M |
| DM | 2022-05-25 | 2022-05-23+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $53.42 | +6,000 | 3,130 | New | +$320.5K |
| D | 2021-12-29 | 2021-12-29 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $212.49 | -3,082 | 130 | -96% | -$654.9K |
| D | 2021-12-29 | 2021-12-29 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $53.42 | +3,082 | 3,212 | +2,371% | +$164.6K |
| D | 2021-12-27 | 2021-12-27 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $213.31 | -3,082 | 130 | -96% | -$657.4K |
| D | 2021-12-27 | 2021-12-27 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $53.42 | +3,082 | 3,212 | +2,371% | +$164.6K |
| D | 2021-12-22 | 2021-12-22 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $53.42 | +3,082 | 3,212 | +2,371% | +$164.6K |
| D | 2021-12-22 | 2021-12-22 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $202.44 | -3,082 | 130 | -96% | -$623.9K |
| D | 2021-12-21 | 2021-12-20 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $53.42 | +3,082 | 3,212 | +2,371% | +$164.6K |
| D | 2021-12-21 | 2021-12-20 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $200.00 | -3,082 | 130 | -96% | -$616.4K |
| D | 2021-11-29 | 2021-11-24 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $200.64 | -3,083 | 130 | -96% | -$618.6K |
| D | 2021-11-29 | 2021-11-24 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $53.42 | +3,083 | 3,213 | +2,372% | +$164.7K |
| D | 2021-11-24 | 2021-11-22 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $53.42 | +3,083 | 3,213 | +2,372% | +$164.7K |
| D | 2021-11-24 | 2021-11-22 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $200.42 | -3,083 | 130 | -96% | -$617.9K |
| D | 2021-11-17 | 2021-11-17 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $53.42 | +3,083 | 3,213 | +2,372% | +$164.7K |
| D | 2021-11-17 | 2021-11-17 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $201.90 | -3,083 | 130 | -96% | -$622.5K |
| D | 2021-11-15 | 2021-11-15 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $53.42 | +3,083 | 3,213 | +2,372% | +$164.7K |
| D | 2021-11-15 | 2021-11-15 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $203.45 | -3,083 | 130 | -96% | -$627.2K |
| D | 2021-11-10 | 2021-11-10 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $53.42 | +3,083 | 3,213 | +2,372% | +$164.7K |
| D | 2021-11-10 | 2021-11-10 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $200.00 | -3,083 | 130 | -96% | -$616.6K |
| DI | 2021-11-10 | 2021-11-08 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | G - Gift | — | -4,980 | 651.5K | -0.8% | — |
| D | 2021-11-08 | 2021-11-08 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $200.94 | -3,083 | 130 | -96% | -$619.5K |
| D | 2021-11-08 | 2021-11-08 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $53.42 | +3,083 | 3,213 | +2,372% | +$164.7K |
| D | 2021-11-05 | 2021-11-04 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $53.42 | +3,083 | 3,213 | +2,372% | +$164.7K |
| D | 2021-11-05 | 2021-11-04 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $200.00 | -3,083 | 130 | -96% | -$616.6K |
| 2021-09-29 | 2021-09-17 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | G - Gift | $0.00 | -10 | 130 | -7% | $0 | |
| MI | 2021-09-29 | 2021-09-10+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | G - Gift | $0.00 | -5,837 | 656.5K | -0.9% | $0 |
Purchase Sale Sale after option exercise All abbreviations